
Laicuinuo LCN
Retatrutide
Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Laicuinuo LCN between 10 Sep 2025 and 11 May 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).
Finnrick Rating™
Laicuinuo LCN
Retatrutide
Tested 7 Samples
Last test 11 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Laicuinuo LCN
Samples are tested in commercial labs
Tests Count
7
Scores
AVGMINMAX
Last
11 May 2026
First
10 Sep 2025
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 11 May 2026 | View | 20mg | ⚠️ Sample does not contain Retatrutide | below LOQ | January 29, 2026 | No Label / Silver Crimp / Blue Cap | Lab E | Public | ||||
| 19 Mar 2026 | View | 20mg | 20.6mg | 18.5mg | -10.4% | 99.90% | n/a | November 2 2025 | No Label / Gold Crimp / Clear Cap | Lab E | Public | |
| 19 Mar 2026 | View | 10mg | (no batch claim) | 8.75mg | -12.5% | 99.90% | n/a | (no batch ID) | White Label / Silver Crimp / Green Cap | Lab E | Public | |
| 20 Feb 2026 | View | 10mg | (no batch claim) | 11.2mg | +12.0% | 99.70% | n/a | 12/15/2025 | White Label / Silver Crimp / Green Cap | Lab G | Public | |
| 18 Nov 2025 | View | 5mg | (no batch claim) | 5.1mg | +2.0% | 99.76% | n/a | 250904-VIN-001 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 17 Oct 2025 | View | 10mg | (no batch claim) | 9.68mg | -3.2% | 99.74% | n/a | RT10 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 10 Sep 2025 | View | 10mg | (no batch claim) | 10.8mg | +8.0% | 99.95% | n/a | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |